MediHelp
藥物交互作用 A–Z
已知的藥物–藥物交互作用，包含嚴重程度、作用機轉及臨床處置。
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
- Acalabrutinib + Erythromycin Moderate
- Acalabrutinib + Eslicarbazepine Moderate
- Acalabrutinib + Esomeprazole Major
- Acalabrutinib + Etoposide Moderate
- Acalabrutinib + Famotidine Moderate
- Acalabrutinib + Fluconazole Moderate
- Acalabrutinib + Fludarabine Moderate
- Acalabrutinib + Fluorouracil Moderate
- Acalabrutinib + Fluvastatin Minor
- Acalabrutinib + Fluvoxamine Moderate
- Acalabrutinib + Ganciclovir Moderate
- Acalabrutinib + Gemcitabine Moderate
- Acalabrutinib + Glyburide Minor
- Acalabrutinib + Glyburide-metformin Moderate
- Acalabrutinib + Heparin Moderate
- Acalabrutinib + Hydroxyurea Moderate
- Acalabrutinib + Idarubicin Moderate
- Acalabrutinib + Ifosfamide Moderate
- Acalabrutinib + Imatinib Moderate
- Acalabrutinib + Interferon alfa 2b Moderate
- Acalabrutinib + Interferon beta 1a Moderate
- Acalabrutinib + Interferon beta 1b Moderate
- Acalabrutinib + Irinotecan Moderate
- Acalabrutinib + Isoniazid Moderate
- Acalabrutinib + Itraconazole Major
- Acalabrutinib + Ketoconazole Major
- Acalabrutinib + Lansoprazole Major
- Acalabrutinib + Lapatinib Moderate
- Acalabrutinib + Ledipasvir-sofosbuvir Minor
- Acalabrutinib + Leflunomide Moderate
- Acalabrutinib + Lenalidomide Moderate
- Acalabrutinib + Levetiracetam Minor
- Acalabrutinib + Linezolid Moderate
- Acalabrutinib + Lomustine Moderate
- Acalabrutinib + Lorlatinib Moderate
- Acalabrutinib + Mebendazole Moderate
- Acalabrutinib + Mercaptopurine Moderate
- Acalabrutinib + Methotrexate Moderate
- Acalabrutinib + Metronidazole Minor
- Acalabrutinib + Mifepristone Major
- Acalabrutinib + Mitomycin Moderate
- Acalabrutinib + Mitoxantrone Moderate
- Acalabrutinib + Netupitant-palonosetron Moderate
- Acalabrutinib + Nevirapine Major
- Acalabrutinib + Nicardipine Moderate
- Acalabrutinib + Nilotinib Moderate
- Acalabrutinib + Nitrofurantoin Minor
- Acalabrutinib + Nizatidine Moderate
- Acalabrutinib + Omeprazole Major
- Acalabrutinib + Oxaliplatin Moderate
- Acalabrutinib + Oxcarbazepine Moderate
- Acalabrutinib + Paclitaxel Moderate
- Acalabrutinib + Pantoprazole Major
- Acalabrutinib + Pazopanib Moderate
- Acalabrutinib + Peginterferon alfa 2a Moderate
- Acalabrutinib + Peginterferon alfa 2b Moderate
- Acalabrutinib + Phenytoin Major
- Acalabrutinib + Pitavastatin Moderate
- Acalabrutinib + Posaconazole Major
- Acalabrutinib + Primaquine Moderate
- Acalabrutinib + Procarbazine Moderate
- Acalabrutinib + Pyrimethamine Moderate
- Acalabrutinib + Rabeprazole Major
- Acalabrutinib + Ribociclib Moderate
- Acalabrutinib + Rifampicin Major
- Acalabrutinib + Rivaroxaban Major
- Acalabrutinib + Rosuvastatin Moderate
- Acalabrutinib + Secobarbital Major
- Acalabrutinib + Sertraline Minor
- Acalabrutinib + Siponimod Moderate
- Acalabrutinib + Sofosbuvir Minor
- Acalabrutinib + Sofosbuvir-velpatasvir-voxilaprevir Minor
- Acalabrutinib + Sulphasalazine Moderate
- Acalabrutinib + Sunitinib Moderate
- Acalabrutinib + Temozolomide Moderate
- Acalabrutinib + Tenofovir alafenamide Minor
- Acalabrutinib + Tenofovir disoproxil Minor
- Acalabrutinib + Thioguanine Moderate
- Acalabrutinib + Ticagrelor Major
- Acalabrutinib + Ticlopidine Moderate
- Acalabrutinib + Tirofiban Major
- Acalabrutinib + Topotecan Moderate
- Acalabrutinib + Verapamil Moderate
- Acalabrutinib + Vinorelbine Moderate
- Acalabrutinib + Voriconazole Major
- Acalabrutinib + Warfarin Moderate
- Acalabrutinib + Zidovudine Moderate
- Acamprosate + Bupropion-naltrexone Minor
- Acamprosate + Diazepam Minor
- Acamprosate + Naltrexone Minor
- Acarbose + Activated charcoal Minor
- Acarbose + Aescin Minor
- Acarbose + Albiglutide Minor
- Acarbose + American ginseng Minor
- Acarbose + Amitriptyline Minor
- Acarbose + Amlodipine-hydrochlorothiazide-valsartan Minor
- Acarbose + Amlodipine-olmesartan-hydrochlorothiazide Minor
- Acarbose + Aripiprazole Minor
- Acarbose + Asenapine Moderate
- Acarbose + Atazanavir Minor
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
